Krishna Institute of Medical Sciences Limited — Important, 06-02-2025: Financial Result Updates

**Consolidated Financial Summary for KIMS Hospitals**

Total revenue for the quarter ended December 31, 2024, is Rs. 3,681 crore, reflecting a year-over-year growth rate of 10%. This growth is driven by increased patient admissions and expansion into new geographical markets, demonstrating the company's successful strategy in enhancing service offerings.

The consolidated net profit for the same period stands at Rs. 621 crore, up from Rs. 573 crore a year ago, translating to an Earnings Per Share (EPS) of Rs. 2.08 compared to Rs. 1.90 previously. This increase in profitability can be attributed to improved operational efficiencies and reduced costs in supply chain management despite rising inflation in medical supplies.

Total expenses have increased by 5% to Rs. 3,200 crore, primarily due to higher personnel costs and expansion-related expenditures. However, the operational cost management continues to reflect positively on the bottom line.

On the balance sheet, total equity capital remains strong at Rs. 5,500 crore, with other equity netting Rs. 1,783 crore. Cash flow for the quarter indicates robust liquidity, ensuring the company is well-positioned to support ongoing and future expansion plans.

Strategically, KIMS Hospitals appears committed to consolidating its market position through innovative healthcare delivery models and continuous operational improvement. The outlook remains optimistic, with expectations of further growth and enhanced market share in the coming quarters.

Given these positive indicators related to revenue growth, profitability, and strategic positioning, the suggestion for investors would lean towards a buy stance, as KIMS shows promising potential for continued success in the healthcare sector.